Acne vulgaris in a 22‐year‐old cystic fibrosis patient treated with Elexacaftor‐Tezacaftor‐Ivacaftor and good clinical response to isotretinoin—A case report

URN to cite this document:: urn:nbn:de:bvb:355-epub-591561
DOI to cite this document:: 10.5283/epub.59156

Pfeiffer, Isabelle ; Berneburg, Mark

; Hopfner, Zeljka ; Niebel, Dennis

License: Creative Commons Attribution Non-commercial No Derivatives 4.0
PDF - Published Version
(4MB)

Date of publication of this fulltext: 12 Sep 2024 06:49

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Cystic fibrosis (CF) is a rare autosomal recessive genetic disorder that is now commonly treated with cystic fibrosis transmembrane conductance regulator (CFTR) modulators. Typical adverse events comprise new onset (drug-induced) acneiform eruption as well as worsening of pre-existing acne vulgaris. We present a case report of a young adult with rapid CFTR-modulator-induced worsening of ...